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THE MOLECULAR EPIDEMIOLOGY OF METHICILLIN-RESISTANT 
STAPHYLOCOCCUS AUREUS (MRSA) IN THE MAJOR COUNTRIES OF 
EAST ASIA 
 
EUGENE JOH 
ABSTRACT 
 Methicillin-resistant Staphylococcus aureus (MRSA) is a successful 
pathogen which was historically found in hospital settings but now is a common 
cause of infection in communities. The rapid emergence of community-acquired 
MRSA (CA-MRSA) at the turn of the 21st century has established this bacterium’s 
presence throughout the globe and MRSA continues to be endemic in certain 
countries. Asia is the most populous continent in the world and also holds a high 
burden of MRSA infection. This presents a concern for both public health and the 
acquisition of antibiotic resistance in this region. This literature review describes 
how MRSA became a successful pathogen. It provides a systematic review of 
the recent literature on MRSA in East Asia to identify major MRSA clones by 
country as determined by their molecular characteristics. Also to identify notable 
genetic and epidemiological factors associated with these MRSA clones. 
The results of this review provided evidence of the importance of using 
molecular categorization techniques to accurately distinguish MRSA strains that 
require specific antibiotic treatment methods. It also provided evidence of CA-
MRSA clones invading hospital settings and traditional hospital-acquired MRSA 
		 v 
(HA-MRSA) clones continuing to develop multi-drug resistance throughout East 
Asian countries. The results also detected novel MRSA strains across hospitals 
and reported the spread of major MRSA clones within and between countries. 
Strengthening existing surveillance systems and collaborative efforts between 
countries within Asia should be a priority to monitor the evolution and movement 
MRSA especially in the age of globalization and accessible travel. 
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INTRODUCTION 
 
History of Staphylococcus aureus 
Staphylococcus aureus (S. aureus) is a gram-positive bacterium currently 
recognized as a major pathogen to humans due to its ubiquitous geographical 
distribution and rapid evolution documented in the early 21st century. S. aureus 
was first identified circulating within hospitals and now is a known cause for 
widespread infection in communities. Prior to discovery of antibiotics, S. aureus 
carried a high burden of morbidity and mortality where invasive bloodstream 
infections bore an 80% mortality rate [63]. The emergence of antibiotic resistance 
in S. aureus was identified only a few years after the introduction of penicillin in the 
1940s [5]. In the 1960s, after the development of methicillin a semi-synthetic 
penicillin class antibiotic, another wave of resistance was reported from a hospital 
in the United Kingdom where methicillin-resistant S. aureus (MRSA) was first 
isolated. Soon after in the following two decades, reports of MRSA occurred 
throughout Europe and the United States [83]. During this time period, MRSA was 
acknowledged as a nosocomial pathogen causing serious infection in ill patients. 
However, reports of MRSA infection of community origin began to appear in the 
late 1990s with etiologies genetically unique to the isolates identified in healthcare 
settings [65]. These events coined the terms hospital-acquired MRSA (HA-MRSA) 
and community-acquired MRSA (CA-MRSA) to distinguish these new strains. CA-
MRSA is known to typically manifest as and be the primary cause of skin and soft-
tissue infections [20, 58]. Soon after its emergence, different lineages of CA-MRSA 
	 2 
were reported in the Americas, Europe, Africa, Asia and Oceania, establishing its 
presence at an international scale. Due to this pathogen’s rapid geographic 
dissemination and evolutionary trajectory, the Center for Disease Control and 
Prevention (CDC) in the United States and other similar entities around the world 
have recognized MRSA to be a major concern and threat to public health [2]. 
 
Epidemiology of Community-Acquired MRSA 
Prior to the 1990s, infection with MRSA was thought to only occur in 
healthcare settings amongst at-risk groups that included the elderly, patients of 
invasive surgery or intravenous treatments, the chronically ill and those with 
comorbidities such as diabetes and HIV [20]. Other risk factors included previous 
hospital exposure, length of stay in hospitals and exposure to others infected with 
MRSA [65, 15]. The emergence of CA-MRSA was characterized by outbreaks in 
communities without contact to healthcare centers. This had led to many 
epidemiological studies investigating which populations are at high-risk and 
identifying risk factors for CA-MRSA infection. The first reports of MRSA infection 
in communities without traditional hospital risk factors associated with HA-MRSA 
occurred in Australia [13] and then in the United States during the late 1990s [20]. 
The following decade produced a large amount of literature identifying 
epidemiological determinants for CA-MRSA infection for the major strains primarily 
circulating in the United States and in Europe [74]. Unlike their nosocomial 
counterparts, CA-MRSA infection outbreaks occurred in both healthy children and 
	 3 
adults whom were seemingly low risk populations. Further outbreak investigations 
have identified CA-MRSA to disproportionally affect certain populations which 
include ethnic minority groups, infants, those of low socio-economic status, 
homeless populations, IV drug users, prisoners, men who have sex with men, 
athletes, emergency department patients, military personnel, indigenous 
populations and occupational livestock workers [14, 68, 83]. Additional host risk 
factors include those who are immunocompromised, diabetic, having cystic fibrosis 
and positive HIV status [83, 12]. Some of these studies alongside others have 
identified additional risk factors for CA-MRSA which include poor sanitation, 
crowding, shared equipment or hygienic products, settings with high risk for 
superficial skin wounds and lack of access to medical care [83]. Due to the 
epidemiological differences between HA- and CA-MRSA cases, the CDC 
proposed a CA-MRSA case definition dependent on the absence of certain 
epidemiological risk factors found in HA-MRSA and a temporal condition if a MRSA 
isolate is obtained within 48 hours of hospital admission [2]. Many studies 
categorizing cases in healthcare centers use this definition as an MRSA isolate 
obtained ≤48 hours after admission and HA-MRSA as an isolate obtained >48 
hours after admission. All references to CA-MRSA and HA-MRSA in this literature 
review will be based on this definition unless specified. However, this definition has 
become less reliable due to the occurrence of HA-MRSA strains in the community 
and CA-MRSA emerging in healthcare settings, causing a blurring between these 
definitions [7, 47].  CA-MRSA clones have been reported to cause hospital 
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outbreaks in neonate units, newborns, post-operative patients, healthcare workers 
and their household members [14]. This leads to the emphasis of standardized 
methods and definitions for identifying strains of MRSA based on their molecular 
characteristics. The use of molecular typing is useful for identifying groupings of 
MRSA clones which can provide crucial information during an outbreak 
investigation or active nationwide surveillance. 
 
Molecular Typing Methods for MRSA 
To date, MRSA has been typically characterized by antibiotic susceptibility 
patterns and molecular typing by DNA fragment restriction profile pulsed-field gel 
electrophoresis (PFGE), select house-keeping genes by multilocus sequence 
typing (MLST), protein A (spa) typing, staphylococcal cassette chromosome mec 
(SCCmec) element typing, and the presence of virulence genes. It is important to 
note that molecular typing for MRSA has been pushing towards whole-genome 
sequencing (WGS) due to it’s high level of resolution and discrimination between 
strains [34]. Table 1 outlines general methods, advantages and examples of 
common nomenclature for the abovementioned MRSA molecular typing 
techniques in the order of discriminatory power from WGS to SCCmec. Early 
investigations have previously associated the carriage of Panton-Valentine 
Leukocidin (PVL) genes as a marker for CA-MRSA but further studies have 
identified that some community-acquired isolates do not contain PVL genes [81]. 
The identification of PVL has now only served to provide further resolution for 
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molecular classification and suggestive differences in clinical manifestations for 
MRSA infection [14]. 
WGS, as the name implies, involves the sequencing of genetic material in 
its entirety. This clearly gives this method the one of highest levels of resolution in 
discriminating between clones and strains but it is time-consuming and difficult to 
achieve in a clinically relevant time period. PFGE compares banding patterns of 
DNA fragments produced by restriction-enzyme digests and it is the “gold-
standard” for outbreak investigations due to it’s ability to distinguish closely related 
strains. Despite the advantages of PFGE, it is technically difficult and time 
consuming. Also results of this method are also difficult to compare between 
laboratories and between different time periods. Notable examples of this 
classification based on the PFGE database from the United States are the major 
clones known as USA300, USA400, USA1000. Spa typing is based on sequencing 
polymorphisms in the spa gene that encodes the surface protein A (spa). It is cost-
effective compared to PFGE and MLST with unambiguous data but 
misclassification of lineages can occur using this method. Spa typing currently 
uses two types of nomenclature systems, Ridom and eGenomics [66]. MLST is 
based on seven select house-keeping genes found throughout the genome where 
the fragments are sequenced and identified using a MLST database 
(http://saureus.mlst.net). Variations in each of the genes are considered to be 
alleles and are then combined to create unique profiles called sequence types 
(STs). It is important to note that there is a good level of congruence between 
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PFGE, spa typing and MLST [66]. Clonal Complexes (CC) are groups where STs 
share common allelic profiles. This method of categorization has been useful in 
grouping related clones using the eBURST program (http://eburst.mlst.net). It is 
typical to find variants of major STs within the same CC’s.  
SCCmec typing classifies different SCCmec elements into one of eleven 
currently known types identified in the literature and stored in an online database 
(http://www.staphylococcus.net/) [62]. The most common molecular 
characterization method and nomenclature for MRSA is the use of SCCmec typing 
paired with ST to describe different clones with further resolution. This method has 
been useful to identify major clones of MRSA that have spread globally to various 
countries [58, 17]. Historically CA-MRSA strains have been differentiated from HA-
MRSA strains based on SCCmec type [62]. CA-MRSA has been mainly associated 
with SCCmec type IV and occasionally with type V which both confer only beta-
lactam resistance [14]. In comparison, HA-MRSA clones typically carry SCCmec 
types I, II, III containing additional multidrug resistance genes [52]. Turlej et al. 
provides a concise summary for the STs associated with SCCmec and the 
presence of resistance genes mecA and ccr [78]. 
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Table 1. Molecular characterization techniques for MRSA 
This table displays each of the molecular characterization techniques used for MRSA in 
the order of resolution with whole-genome sequencing being the highest down to SCCmec typing. 
A brief description, advantages and limitations of each technique are described with an example of 
the nomenclature used for a predominant CA-MRSA clone in the United States known as USA300 
or ST8-IV-t008. *spa typing by Ridom and eGenomics systems respectively. 
 
Method Description Advantages and Limitations 
 
Example 
Nomenclature of 
CA-MRSA clone 
 
Whole-genome 
sequencing [13] 
Genome of the isolate is 
sequenced in it’s 
entirety 
Highest resolution for strain 
discrimination but time-
consuming with high cost 
 
Not applicable 
Pulsed-field gel 
electrophoresis 
[61] 
Banding patterns of 
genomic DNA from 
isolates are compared to 
reference strains 
High level of discriminative 
power between clones in 
short time periods but 
difficult inter-laboratory 
comparison 
 
USA300  
Protein A (spa) 
typing [53] 
Amplification of spa and 
sequences are 
compared to online 
databases  
Discriminatory power 
between MLST and PFGE 
t008 or 1* 
Multilocus 
sequence typing 
[16] 
Fragments of house-
keeping genes are 
sequenced to create an 
allelic profile 
Analysis is unambiguous 
and advantageous 
grouping of clonal 
complexes, good for long-
term evolution and clonal 
changes but time 
consuming 
 
ST8 
Staphylococcal 
cassette 
chromosome 
mec typing [78] 
mec and ccr genes are 
sequenced then genetic 
and structural 
characteristics are 
compared 
Identification based on 
antibiotic resistance genes 
useful for epidemiological 
studies but time consuming 
and technically difficult 
 
Type IV 
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Antibiotic Resistance of S. aureus 
Penicillin was first introduced in the 1940s as a revolutionary treatment of 
previously fatal bacterial infections including S. aureus. However, after it’s 
discovery and use, resistance to penicillin in S. aureus quickly developed by the 
acquisition of a beta-lactamase. The second wave of resistance in S. aureus 
occurred only two years after methicillin was introduced in 1961 [5]. This is in 
comparison to vancomycin, a glycopeptide antibiotic first used in 1958, where 
resistance in S. aureus took almost 40 years to achieve [69]. The origins of 
methicillin resistance acquisition in S. aureus has been thought to have occurred 
through the horizontal transfer of the mecA resistance gene from another 
staphylococci species [77]. CA-MRSA clones tend to be susceptible to beta-lactam 
antibiotics, but increasing evidence of multi-drug resistance of CA-MRSA clones 
has led to concerns over available treatment options [18]. Resistance has been 
found in certain beta-lactams, glycopeptides, quinolones, aminoglycosides, 
fusidanes, macrolides and lincosamides. The susceptibility of MRSA isolates is 
typically determined by evaluating the minimal inhibitory concentration (MIC), 
which is the minimal concentration of an antibiotic necessary to inhibit the grow of 
the MRSA isolate. The summary of resistance rates for various antibiotics gives a 
unique antibiotic resistance profile to tested isolates. 
Different STs and SCCmec types have been known to contain distinct 
resistance profiles. MRSA strains that are traditionally hospital-acquired and 
contained SCCmec types II and III typically have resistance to multiple antibiotics. 
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CA-MRSA strains which are classically SCCmec types IV and V tend to be 
susceptible to more antibiotics. Chua et al. provides the antibiotic profiles for 
resistance by ST, SCCmec type and PVL status for major global clones of MRSA 
[9]. Resistance patterns differ by major clones throughout the world, within 
continents and even within countries there is heterogeneity for resistance profiles. 
Potential for increased resistance is always a threat which requires the active 
development of new antibiotics and appropriate usage of existing antibiotics to 
prevent the development of further resistance. 
 
Carriage and Clinical Symptoms of CA-MRSA 
S. aureus is the most commonly isolated agent in skin and soft tissue 
infections and has been the causative agent of clinical symptoms which range from 
self-limiting to severe in nature. There are high rates of colonization of S. aureus 
in people with common sites occurring in the nares, throat, axilla, groin, breast, 
hands, neck and rectal region [15]. Carriers of CA-MRSA have a higher risk of 
infection compared to those without colonization and also serve as a reservoir for 
the spread of MRSA in communities [14]. CA-MRSA has been associated with skin 
and soft tissue infection with clinical presentations of abscesses and cellulitis being 
most common. Other manifestations include erysipelas, folliculitis, impetigo, 
lymphadenitis, carbuncles, and furuncles. Some strains have been identified to 
cause severe and invasive disease such as necrotizing fasciitis, osteomyelitis, 
pneumonia, endocarditis, sepsis, myositis, and pyomyositis [28, 14]. 
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Major International CA-MRSA Clones 
Since the first reported case of CA-MRSA, unique genotypes of CA-MRSA 
began to rapidly appear across each continent. Some of these CA-MRSA clones 
were geographically limited to their location of origin while other “international” 
clones were successful in causing outbreaks in distant locations far from where 
they first isolated. MLST and SCCmec typing have established only a few major 
international clones and their closely related genetic variants. 
Table 2 contains the predominant CA-MRSA clones in various world regions 
by ST and SCCmec types. The major CA-MRSA clones that have been identified 
in the literature include ST1-IV, ST8-IV, ST30-IV and ST59-V. Despite not being 
the dominant clones in all continents, ST8-IV and ST30-IV are considered to be 
truly global clones as they are the only clones that have been isolated from all 
continents except for Antarctica [45]. 
 CA-MRSA has been well documented in the United States since the first 
outbreak in the Midwest from 1997-1999 [3]. During the time period before 2001, 
the ST1-IV strain or USA400 was the most prevalent CA-MRSA strains. However, 
a shift occurred to ST8-IV with PVL genes or USA300 becoming the predominant 
strain and leading cause of all community-acquired bacterial infections in the 
United States [44]. USA300 has continued in it’s geographical spread to Canada 
and has also been isolated in Europe, the Middle East, Asia, Africa and Oceania 
[50, 51]. 
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Europe’s predominant CA-MRSA clone is ST80-IV, which has been isolated 
in Austria, Belgium, Bulgaria, Czech Republic, Denmark, Finland, France, 
Germany, Greece, Netherlands, Norway, Poland, Romania, Spain, Slovenia, 
Sweden, and Switzerland [55, 60]. There is a high level of genetic heterogeneity 
of CA-MRSA despite it’s lower prevalence compared to the United States [67]. 
There is evidence that ST80-IV may have originated from northern Africa before 
becoming the most widely distributed CA-MRSA clone in Europe [67]. 
In South America, there have been limited studies on the molecular 
epidemiology of CA-MRSA, but regional differences in predominant strains have 
been identified. ST5-IV has been identified as the major clone in the northern 
portion of South America and Argentina [64]. MRSA in Brazil has been 
characterized by HA-MRSA strains’ proliferation into communities, while a non-
multidrug resistant CA-MRSA isolates are being found in hospital settings [59]. 
 Similar to South America there is limited data on the molecular 
characteristics of CA-MRSA in Africa. ST88 with SCCmec types III and V (ST88-
III/V) are the major MRSA clones throughout all regions of Africa except for 
northern Africa where ST80-IV is the predominant clone. ST88-III/V is rarely found 
elsewhere in the world except for South East Asia [1]. 
Isolates in Asia also contain a wide range of genetic diversity relative to the 
United States. However, the ST59 clone has established itself in multiple countries. 
In Taiwan, the majority of isolates are of ST59 [45]. ST59 in China is not as 
prevalent compared to Taiwan. Most Asian CA-MRSA isolates do not carry PVL 
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genes with the exception of known imported cases. This is true in South Korea 
where ST89 and ST8 without PVL genes are the major clones. CA-MRSA in Japan 
is molecularly diverse but cases of both multidrug resistant USA300 and imported 
USA300 have been reported. ST59-V with PVL genes from Taiwan has also been 
established in Japan since 2010 [10]. 
Australia has two major CA-MRSA clones, ST93-IV and ST30-IV. ST93-IV 
has become the predominant clone since 2008 and it has been linked to both skin 
and invasive infections. ST30-IV originated from New Zealand where it was the 
predominant clone until 2005, after which ST5-IV became dominant. Despite this 
ST30-IV has successful spread to North America and Europe [85]. 
 
Table 2. Major CA-MRSA Clones in the World 
 This table lists the major CA-MRSA clones from each region in the world. The clones listed 
are predominant clones based on literature reviews for each region [1, 44, 45, 64, 67, 85]. 
 
Region Major CA-MRSA Clones 
Asia ST59-IV/V 
North America ST8-IV, ST1-IV 
Europe ST80-IV, ST398-IV/V 
Oceania ST1-IV, ST30-IV, ST93-IV 
Africa ST88-III/V, ST80-IV 
South America ST5-IV 
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OBJECTIVES AND METHODS 
The World Health Organization (WHO) has emphasized initiatives to 
combat the developing threat of antimicrobial resistance to both local and global 
public health [84]. The continent of Asia in recent years has been identified to be 
a hotspot for antimicrobial resistance [29, 27]. The rapid emergence and success 
of CA-MRSA strains has demonstrated the pandemic capabilities of a seemingly 
treatable pathogen. In Asia, MRSA is unique by its high prevalence relative to other 
continents and wide genetic diversity between and within countries [25]. The ways 
that S. aureus has already adapted virulence and resistance genes is of concern 
especially in environments that may continue to promote the pathogen’s evolution 
in obtaining antibiotic resistance. The blurring of CA-MRSA and HA-MRSA, by the 
presence of community strains in the hospital setting and vice-versa also stresses 
the need for constant molecular evaluation of these strains. The objective of this 
library thesis is to provide a brief overview of recent literature on the molecular 
epidemiology of MRSA in the major East Asian countries, to identify major MRSA 
clones by their genetic characteristics and to characterize the antibiotic profiles of 
these clones. Using molecular epidemiology to identify changes in major MRSA 
clones serves to make informed clinical and public health decisions. 
This literature review was conducted by searching for observational studies 
and reports on MRSA infection and colonization in East Asia. China, Hong Kong, 
Japan, Mongolia, South Korea and Taiwan were chosen for study as they are the 
major East Asian countries, based on the United Nations Statistical Division’s 
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definition of East Asia [80]. PubMed searches were conducted with the following 
criteria using the MeSH terms “Molecular Epidemiology”[Mesh], “Methicillin-
Resistant Staphylococcus aureus"[Mesh], and “Far East”[Mesh]. The time frame 
for the literature review was within the past 6 years. Additional exclusion criteria 
for the studies were as follows: if a study did not include any one of the genotyping 
techniques: PFGE, MLST and SCCmec typing [12], if the articles were not 
published in English, or if articles lacked appropriate translations of the 
manuscripts. The combined MeSH terms used were as follows:  ("Molecular 
Epidemiology"[Mesh] AND "Methicillin-Resistant Staphylococcus aureus"[Mesh]) 
AND "Far East"[Mesh] AND ("2010/01/01"[PDAT] : "2016/10/15"[PDAT]) 
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Figure 1: Major Countries of the Far East Geographic map 
 This figure displays the major countries of the Far East that were included in this library 
thesis. China in blue, Taiwan in green, South Korea in orange, Japan in purple and Hong Kong in 
red. ArcGIS Pro was used to create the map (ESRI 2016. ArcGIS Pro Desktop: Release 1.1. 
Redlands, CA: Environmental Systems Research Institute, Inc.) using country boundary 
shapefiles provided by GADM | Boundaries without limits (http://www.gadm.org/). 
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RESULTS AND DISCUSSION 
Based on the MeSH terms and exclusion criteria, 26 primary literature 
articles of human observational studies and reports with relevant molecular 
epidemiology information of CA-MRSA were found. These investigations were 
conducted in China, Hong Kong, Japan, South Korea, and Hong Kong, while there 
was none for Mongolia. The distribution of the articles by country is as follows: 9 
from China, 1 from Hong Kong, 6 from Japan, 3 from South Korea and 7 from 
Taiwan. Twenty-two studies examined samples from hospitals while two studies 
were conducted in nursing homes and one in a child daycare center. Of the 26 
studies, six considered colonization of MRSA for their investigations while the 
remainder were based on only MRSA infection. 23 studies tested for antimicrobial 
susceptibility. All 26 studies used SCCmec for molecular characterization of MRSA 
isolates, while 22 studies also used MLST and half also used PFGE and spa 
typing. Approximately on average three of the four listed molecular 
characterization techniques were used in each study. 19 studies specified the sites 
where samples for S. aureus isolates were taken. Skin and blood were the most 
common sample sites for MRSA isolates and multiple sampling sites were used in 
13 studies. A unique note is that one study investigated the molecular 
epidemiology of MRSA isolates from ocular infection. 
 
	 17 
MOLECULAR EPIDEMIOLOGY 
China 
 Of the 9 results from the the literature search in China, 8 studies in China 
which were conducted in hospital settings primarily focusing on MRSA infection. 
ST239-III has been reported to be the dominant hospital-associated clone in China 
since the 1990s [7]. This clone along with ST5-II were the most commonly isolated 
clones (Table 3) Cheng H et al. investigated the characteristics of these two 
predominant clones from teaching hospitals found in six cities across the country 
[8]. Samples were taken from January 2009 to March 2012 from patients. There 
was an average 59.8% prevalence of MRSA in all isolates. Interestingly there was 
higher prevalence in hospitals found in coastal cities compared to hospitals in cities 
located further inland. The most common SCCmec type was III constituting 57.6% 
of all isolates, and it was followed by SCCmec II and IV which represented 22% 
and 8% respectively. From MLST, 15 STs were identified including 4 new STs. 
This study suggests a wide distribution of these major clones in China due to their 
prevalence in multiple hospitals across the entire country. Tian et al. also reported 
ST239-III and ST5-II from MRSA isolates collected during 2002 to 2008 from three 
hospitals in Shenyang, China which is geographically adjacent to the Korean 
peninsula [75]. ST239-III was found in higher prevalence than the ST5-II clone. 
The predominance of ST239-III was also seen in the study by Xiao et al. where 
HA-MRSA isolates were obtained in the first 6 months of 2011 from 69 hospitals 
from 45 large cities for nationwide surveillance in China [86]. Based on the 1,141 
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MRSA isolates, over 30 STs were identified with ST239-III being the most common 
followed by ST5-II and ST59-IV. Xie et al. confirmed the predominant distribution 
of ST239-III based on a study from southern Guangzhou province [87]. Based on 
inpatient MRSA samples from 2006 to 2011, 12 STs were identified with ST239-III 
being the most prevalent. This study also compared clinical demographic 
information and clinical symptoms between HA-MRSA and CA-MRSA infection 
[87]. This study reported variability in PVL genes across both HA-MRSA and CA-
MRSA isolates suggesting that PVL is not a reliable molecular indicator to identify 
CA-MRSA from HA-MRSA in China. This is similar to a multisite healthcare study 
reported the variability in PVL genes from isolates was seen between PFGE 
pulsotypes [40]. Also Yao et al. reported high prevalence of PVL genes in both HA-
MRSA and CA-MRSA isolates in China [88]. 
Yao et al. investigated the molecular epidemiology of MRSA isolates from 
skin and soft tissue infections, a common clinical manifestation of CA-MRSA, at a 
teaching hospital from December 2002 to June 2008 [88]. 54% of skin and soft 
tissue infection isolates were MRSA. 66.7% of the MRSA isolates were hospital-
associated based on the CDC definition mentioned earlier. ST239-III was the 
predominant ST in both HA- and CA-MRSA isolates with ST5-II being second most 
prevalent. SCCmec types III and IV were the most commonly found in HA- and 
CA-MRSA isolates respectively. The blurring of the CDC definition of hospitals 
versus community acquired infection is seen in this study. Despite skin and soft 
tissue infections being the major clinical manifestation of CA-MRSA, ST239-III a 
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HA-MRSA clone was identified to be the predominant clone causing these 
infections in this study. This gives evidence of HA-MRSA clones causing clinical 
symptoms typically associated with CA-MRSA clones while ST239-III still remains 
to the predominant clone in hospitals across China. Despite the predominance of 
ST239-III and ST5-II throughout Chinese hospitals, Li J et al. identified ST59-IV 
and ST59-V to be the dominant clones from isolates taken from pediatric and 
university hospitals across China from 2005 to 2011 [39]. This study was the first 
to report CA-MRSA strains belonging to the same clonal cluster, CC59, in children 
from Chinese hospitals. Li S et al. also investigated the prevalence of virulence 
genes in child patients in four regional hospitals from 2004 to 2012 [40]. Isolates 
were taken from multiple sites which identified 22 STs of which ST59-IV (35.8%) 
was the most prevalent followed by ST239-III (22.6%). This provides further 
support that the ST59 MRSA clone is invading hospital centers.  
The major hospital-associated clones in China are still of concern due to 
their recognized broad range of antibiotic resistance associated with SCCmec 
types I, II and III. Zhang H et al. conducted a multi-center study of MRSA skin 
infections to compare the molecular characteristics of isolates to their susceptibility 
to ceftaroline, a newly developed cephalosporin [89]. HA-MRSA samples were 
taken from 56 hospitals during the same time period as the nationwide study done 
by Xiao et al. [86]. Based on these isolates, they determined that the majority of 
non-susceptible isolates belonged to a single clonal cluster and that ST239-III 
contributed to the majority of ceftaroline resistant isolates. There was also 
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evidence of continued evolution based on clones with single nucleotide mutations 
in ST239-III within the same clonal complex.  
The overlap of HA-MRSA and CA-MRSA clones in other settings outside of 
hospitals was also seen in study by Zhang J et al. of MRSA colonization in multiple 
nursing homes within Shanghai [90]. Samples were taken over a one-month period 
in 2014. The overall prevalence of MRSA was 10.6% and 18 different STs were 
identified. The predominant ST differed between sampling sites where ST1 was 
the most common for nasal swabs, axillary samples were both ST1 and ST398, 
and ST398 for skin samples. This study demonstrated that a single individual can 
be colonized with multiple strains in different body sites which has important 
implications for screening and elimination of MRSA for patients. Nursing homes 
are an interesting intersection between the community and healthcare settings 
where the distribution and sources of CA-MRSA and HA-MRSA require further 
investigation. 
 The studies of MRSA in China demonstrate the wide range of genotypic 
diversity in the country, not only within individual healthcare centers but across the 
country in different regions. The identification of novel STs is also notable as Yao 
et al. reported 3 novel STs over a 6-year period from a single teaching hospital 
[88]. Cheng et al. and Xiao et al. both conducted studies from multiple hospitals in 
different regions and reported 4 and 15 novel STs respectively [51, 88]. From the 
15 novel STs Xiao et al. reported a single novel ST occurring in two different 
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hospitals in the middle and eastern regions of China suggesting that the 
dissemination of novel clones can occur over large areas [86]. 
Taiwan and Hong Kong 
 MRSA has been heavily studied in Taiwan compared to other East Asian 
countries. HA-MRSA have been reported since the early 1990s with ST254-IV and 
ST239-III being the two major clones [7]. Entering the 2000s, ST239-III became 
the predominant clone and it has disseminated throughout the country. Kuo et al. 
compared the molecular characteristics of patients presenting with bacteremia due 
to CA-MRSA by SCCmec type between 2004 to 2008 in a tertiary healthcare 
center [35]. ST239-III was the most common clone among SCCmec type I while 
ST59 was the most common for SCCmec types II, IV, and V. However, recent 
evidence shows a decrease of ST239-III with an increased prevalence of ST5-II, 
a clone with a known international presence, and ST59-IV [7]. ST5-II is a HA-
MRSA clone first reported in 2006 from a respiratory care ward outbreak in Central 
Taiwan [38]. All the studies in Taiwan from this literature review reported the 
presence of ST59-IV in isolates taken from hospitals, nursing homes and day cares 
throughout Taiwan. Similar to China, the invasion of traditional CA-MRSA into 
healthcare settings is seen with the presence of ST59-IV in epidemiologically 
defined HA-MRSA infections. Ho et al. analyzed isolates from blood samples taken 
from patients in a university hospital over a five-month period in 2008 [21]. ST5-II 
and ST239-III were the predominant clones with ST59-IV/V being the third most 
prevalent clone. Despite the decreasing predominance of ST239-III in Taiwan, this 
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clone is still of concern as Lin et al. reported intermediate levels of resistance to 
vancomycin (MIC between 4 to 8 µg/ml) during 2009 in a teaching hospital [41]. 
Based on 118 patients, a 4.2% prevalence of vancomycin resistance in all S. 
aureus isolates and 8.1% vancomycin resistance in MRSA isolates were reported. 
In the vancomycin resistant isolates, five different PFGE pulsotypes were found, 
each unique to the five patients. MLST determined ST239-III and its single locus 
variant to be the predominant clones from the four of the five patients while the 
other isolate was ST5-II. This is the highest rate of vancomycin resistant S. aureus 
in Taiwan but it is lower compared to a multi-city study in China (13.1%) [70]. 
Earlier, from 2001 to 2002, Hsueh et al. identified the expansion of a single 
pulsotype with SCCmec type III from 21 patients in Taipei teaching hospital [24]. 
This investigation demonstrated the ability of a single clone with intermediate 
vancomycin resistance to spread within a healthcare facility. The results from this 
study emphasize the selective pressure of antibiotic use and indicate the 
importance of proper antibiotic treatment in preventing the emergence of antibiotic 
resistant clones. The development of vancomycin resistance in ST239-III major 
clone and evidence of clonal spread in Taiwan demands for increased monitoring 
and molecular surveillance to prevent the expansion of a vancomycin resistant 
outbreak or epidemic. 
The importance of MRSA infection control was seen in the outbreak 
investigation in 2006 within a Taiwanese respiratory care ward [38]. The spread of 
a single dominant clone in this respiratory ward demonstrated the potential of 
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transmission between patients and healthcare workers in a hospital setting. 
Samples taken from both patients and healthcare workers identified ST5-II as the 
most commonly isolated clone in both groups. This was the first report of ST5-II in 
Taiwan, although it was a common HA-MRSA clone in Japan and South Korea 
prior to 2006 [33]. This outbreak was also the first to report ST45-V in Taiwan, 
originating from Europe [14]. It is an interesting note that Tsao et al. reported this 
specific strain from colonization swabs taken from residents and staff during the 
summer of 2012 across 14 nursing homes [76]. The majority of SCCmec types in 
this study were IV and V (71.4%) compared to the less common SCCmec types II 
and III (8.4%). ST45-IV/V (30%) was most common followed by ST30-IV (12%) 
and ST239-III (5%). There is previous literature on the spread of ST45 throughout 
nursing homes in Taiwan and China [23]. The relationship with ST45 transition into 
being prevalent in nursing homes from a hospital origin requires further 
investigation. There is evidence of increased carriage in nursing residents after an 
acute medical event in a hospital and many have been identified to be HA-MRSA 
clones, in particular ST239-III. The transport of MRSA colonization through these 
transitions may have implications for appropriate screening of new residents for 
infection control purposes.  
Sampling sites for MRSA are typically from blood, skin, nasal, drainage from 
infection sites, and other bodily fluids. Kang et al. presents a unique study on 
characterizing the molecular epidemiology of MRSA from ocular sites [30]. 
Conducted from 2010 to 2011, 59 patients were identified with S. aureus with 34 
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of them being MRSA. The most common clone was ST59-IV/V which is the most 
common CA-MRSA clone in Taiwan. The second most common clone was ST239-
III, historically found in the hospital setting. This demonstrates consistency with the 
distribution of HA- and CA-MRSA clones from non-ocular sites based on 
epidemiological definitions.  
The results of this the literature search found one study based in in Hong 
Kong investigated risk factors associated with colonization of MRSA in children 
among day care and kindergarten centers [22]. This large scale study across 79 
daycare centers and 113 kindergarten centers obtained samples during the 
academic year from 2009 to 2010. The carriage of MRSA was similar between day 
care centers and kindergarten centers with a 1.3% prevalence. ST59 carrying 
SCCmec types IV and V were most common followed by ST45 also with SCCmec 
types IV and V. The isolates were genetically diverse and included strains of ST10-
V and ST1-IV. This was the first report of ST1-IV in Hong Kong. ST10-V is novel 
MRSA genotype while ST1-IV has been found across the world in the United 
States, Europe and Asia [57]. 
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South Korea and Japan 
South Korea has been known to have a high burden of MRSA (>70%) 
compared to other countries in Asia [46,66]. ST5-II, ST239-III, and ST72-IV were 
the most prevalent clones isolated in the three studies from the literature search 
shown in Table 3. ST5-II and ST239-III have been established to be predominant 
clones in South Korean hospitals since the mid 1990s [4]. Kim et al. analyzed 
randomized stored samples from patients in hospitals and nasal swabs from 
healthy individuals over a prolonged period from 1996 to 2005 [32]. ST5-II and 
ST239-III were the most prevalent clones during the study period in both clinical 
and community isolates. It is notable that from community sampling in the years of 
1997-1998 and 2005 the nasal carriage prevalence of MRSA increased from 0% 
to 8% and ST72-IV emerged to be the most common ST for CA-MRSA. This 
predominant CA-MRSA clone is unique due to the lack of PVL genes; a feature 
that is geographically unique to South Korea. CA-MRSA ST72 clones typically 
contain PVL genes are found in North America and Europe [7, 25]. Despite being 
primarily isolated as a community-associated clone there is recent evidence of 
ST72 invasion into healthcare settings [56]. This was evident in a study by Kwon 
et al. where analyzing MRSA bacteremia isolates and nasal swabs across 10 
intensive care units [36]. This group used a different set of definitions compared to 
the CDC, where imported cases were within 72 hours after admission and acquired 
cases was defined as at or more than 72 hours after admission. Seven PFGE 
pulsotypes had the same MLST profile of ST5-II (61.9%) One PFGE pulsotype 
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consisted of all ST72-IV which was 22.5% of all isolates and was the dominant ST 
in hospital-associated cases. Sung et al. investigated MRSA bacteremia among 
pediatric patients in two tertiary hospitals [71]. During the study period from 2006 
to 2010 ST72-IV was most common in both CA-MRSA isolates (62.5%) and HA-
MRSA isolates (41%) from pediatric wards. Other strains identified in this study 
were ST89-II, ST239-II/III and a ST239-III single locus variant. There was a low 
prevalence of PVL genes in CA-MRSA isolates while there was no carriage of PVL 
genes in HA-MRSA isolates. The authors previous study suggests that ST72-IV is 
the predominant clone among healthy South Korean children [37]. A notable 
genotype from this study is ST8-IV (a.k.a. USA300) which is the predominant clone 
from the United States. International spread of this strain was not detected in 
previous South Korean pediatric colonization studies [37]. ST89, a predominant 
Japanese clone, was also identified in this previous study. Sung et al. reported a 
diverse range of STs including one novel ST and several single locus variants. 
 In Japan, the major clones identified from this literature review were ST5-II 
and ST8-IV with a variety of minor clones shown in Table 3. ST30-IV and ST30-I 
were the predominant clones from hospital settings in Japan until ST5-II became 
the dominant clone during the 1990s [42]. This shift was speculated to have 
occurred due the extensive used of antibiotics throughout Japan in the 1980s 
allowing the SCCmec type II, which harbors more multi-resistance genes, to 
influence which MRSA strains would be successful. ST8-IV is also known to be a 
prevalent CA-MRSA clone in the United States and Europe but has been relatively 
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rare in Japan aside from imported cases associated with small outbreaks [25]. The 
ST8 strains that have been identified in Japan typically do not carry the PVL genes 
compared to their USA counterparts. Taguchi et al. conducted an analysis on CA-
MRSA from a small adult inpatient cohort admitted into a university hospital in 
Tokyo from 2008 to 2009 [72]. This is the first report of CA-MRSA strains found in 
critically ill inpatients from Japan. Based on genotyping HA-MRSA strains of ST5-
II contained PVL genes and the CA-MRSA strains contained PVL genes and were 
SCCmec type IV. However, small sample size and study population limits 
generalizability to only suggest importance of detecting the presence of PVL genes 
from critically ill patients in Japan. 
ST5-II was the predominant clone found in the studies conducted by Otsuka 
et al. [54] and Inomata et al. [26]. Inomata et al. analyzed isolates from outpatients 
in a tertiary hospital from 2012 to 2013. The majority of isolates taken from multiple 
body sites were HA-MRSA. A notable finding in this study was the first report of 
ST5-IV in Japan. ST5-IV is a major pandemic clone that has been typically 
detected in the United States, countries in South American, and most recently, in 
South Korea [4, 6]. The presence of an emergent pandemic clone requires further 
analysis of it’s specific microbiology to understand it’s prevalence in Japan. Otsuka 
et al. investigated the MRSA genotypes in children on Sado Island [54]. Sado 
Island is considered to be an area of low antibiotic pressure due to it’s low rates of 
antibiotic use, geographic isolation, and lack of movement of individuals between 
the main island of Japan. Isolates were taken from pediatric outpatients and at 
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checkups for healthy individuals through an island-wide surveillance program. 
Nine STs were reported with ST5-II, ST8-IV, and ST764-II constituting the majority. 
A novel single locus variant of a ST1 strain was also isolated in this study. The 
results provide evidence of HA-MRSA clones appearing in communities outside of 
healthcare settings in low antibiotic pressure environments. ST764-II is a single 
locus variant of ST5-II first identified in Niigata, Japan from 2005 to 2009 [73]. The 
proximity of Sado Island to Niigata may explain the prevalence of ST764-II among 
both healthy and outpatient children. Nakaminami et al. reported ST764-II as the 
predominant clone followed by ST5-II in isolates taken from four tertiary hospitals 
in Tokyo during 2009 [49]. However, the ST764-II isolated in this study was a novel 
clone with different virulence genes from the clones identified in Niigata [31] and 
Hokkaido [73]. This provides evidence of the spread of a novel strain throughout 
various health centers in Tokyo and similarity in the emergence of novel clones 
between different regions within Japan.  
Regional differences in MSRA strains within Japan is further shown by an 
investigation on the southern island of Okinawa from 2008 to 2010 by Mine et al.  
[48]. Samples taken from skin and soft tissue infections of outpatients in clinics 
and hospitals across Okinawa had a prevalence of 36.1% for MRSA, where 6.2% 
contained PVL genes. Only isolates that contained PVL genes were subjected to 
MLST which identified ST8-IV to be the most common among PVL-positive strains. 
This points to the recent emergence and spread of PVL-positive ST8-IV clones in 
Japan. The authors suggest that the high prevalence of strains with PVL genes 
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may be related to the large number of United States military bases on Okinawa. 
Military personnel and groups living in closed quarters such as military barracks 
are known to be at risk for CA-MRSA infection with clones such as ST8-IV with 
PVL genes [14]. Urehara et al. provided a short report on familial MRSA infection 
from a pediatric hospital in Tokyo [79]. Molecular analysis of the isolates from 8 
child and 2 parent cases displayed each family contained a unique strain, 
suggesting the potential transmission of MRSA among family members. ST8-IV 
was found in three families, ST858-IV a single locus variant of ST8 in another 
family, and ST30-IV in a third family. ST30-IV had been a prevalent HA-MRSA 
clone in Japan since the 1980s. However, a shift of spa type, t021 to t019 within 
the endemic ST30-IV Japanese clone resulted in this HA-MRSA clone emerging 
within communities [25]. Urehara et al. provides evidence of risk factors for the 
transmission of CA-MRSA, including close contact and sharing of bathing products 
within families [79].  Suggested transmission prevention methods between family 
members would include hygienic education and proper hygienic practices. 
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Table 3. MRSA Clones Study Results by Country 
 The table shows the predominant and minor clones in the major East Asian countries 
based on the order of prevalence within each study. Notable strains included newly emergent 
strains in the country and novel STs are any strains identified in the study that did not exist in the 
MLST database (http://saureus.mlst.net/). Studies from the literature search that did not utilize 
MLST in their molecular analysis were excluded from this table. *All studies listed were based on 
MRSA infection with the exception of Zhang J et al. [90], Kang et al. [30] and Tsao et al. [76] which 
investigated carriage or colonization of MRSA. 
 
Country Study Predominant 
Clones 
Minor Clones Notable 
China Yao et al. (2010) 
Cheng et al. (2013) 
Li et al. (2013) 
Tian et al. (2013) 
Xiao et al. (2013) 
Li et al. (2014) 
Zhang H et al. (2015) 
Zhang J et al. (2015)* 
Xie et al. (2016) 
ST239-III 
ST239-III, ST5-II 
ST59-IV/V 
ST239-III, ST5-II 
ST239-III 
ST59-IV 
ST239-III 
ST1-I/V 
ST239-III 
ST5-II 
 
 
ST59-IV/V 
ST5-II, ST59-IV 
ST239-III 
 
ST398-V 
 
3 novel 
4 novel 
 
 
15 novel 
 
 
 
 
Hong 
Kong 
Ho et al. (2012) ST59-IV/V ST45-IV/V ST10-V, ST1-IV 
Taiwan Lee et al. (2011) 
Ho et al. (2012) 
Kuo et al. (2012) 
Kang et al. (2015)* 
Tsao et al. (2015)* 
ST5-II 
ST5-II, ST239-III 
ST239-III 
ST59-IV/V 
ST45-IV/V 
ST59-IV 
ST59-IV/V 
ST59-II, ST59-IV/V 
ST239-III 
ST30-IV, ST59-IV 
 
 
 
 
ST1-IV, ST8-IV 
Japan Taguchi et al. (2010) 
Otsuka et al. (2012) 
Mine et al. (2013) 
Nakaminami et al. (2014) 
Inomata et al. (2015) 
Urehara et al. (2015) 
ST5-II 
ST5-II, ST8-IV 
ST8-IV 
ST764-II 
ST5-II 
ST8-IV 
ST8-IV 
ST92-IV, ST59-IV 
 
ST5-II 
 
ST30-IV 
 
1 novel 
 
1 novel 
ST5-IV 
ST858-IV 
South 
Korea 
Kim et al. (2011) 
Kwon et al. (2011) 
Sung et al. (2012) 
ST5-II 
ST5-II 
ST72-IV 
ST239-III 
ST72-IV 
ST239-II/III, ST89-II 
ST72-IV 
 
1 novel 
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ANTIBIOTIC RESISTANCE PROFILES 
China 
From the studies based in China included in this literature review 
ciprofloxacin, clindamycin, erythromycin, gentamicin, rifampicin, trimethoprim-
sulfamethoxazole and vancomycin were the most commonly tested drugs for 
assessing MRSA isolate susceptibility (in Table 4). The majority of studies were 
conducted in hospitals and the samples contain varying proportions of genetically 
unique CA- and HA-MRSA isolates which do not allow direct comparison of the 
resistance rates between studies. Not all the studies provided information on 
whether the investigators stratified the resistance rates by molecularly defined 
differences, such as ST or SCCmec type for comparison. The studies based in 
China demonstrated there is high variability of resistance rates in isolates from 
different body sites, various STs and SCCmec types, and between community-
associated and hospital-associated MRSA clones.  
The known differences for antibiotic resistance profiles between SCCmec 
types II and III versus IV and V (as mentioned earlier), were consistent across the 
studies by Cheng et al. [8], Li et al. [39], Xiao et al. [86], and Xie et al. [87]. The 
study by Cheng et al. showed generally high rates of resistance for all isolates [8]. 
SCCmec types II and III shared the same antibiotic resistance profile with 
resistance rates above 70% for non-beta lactam antibiotics; gentamicin, 
ciprofloxacin, clindamycin, erythromycin, tetracycline, levofloxacin, trimethoprim-
sulfamethoxazole. SCCmec types I and V showed high rates of resistance to three 
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non-beta lactam antibiotics; clindamycin, erythromycin and levofloxacin. ST239-III 
and ST5-II shared the same resistance profile and most isolates of these clones 
were resistant to clindamycin, tetracycline and trimethoprim-sulfamethoxazole. 
Similarly, Tian et al. found that isolates with ST239 and ST5 (HA-MRSA strains), 
were resistant to multiple antibiotics (erythromycin, ciprofloxacin, levofloxacin, 
clindamycin and gentamycin). ST59, an emerging CA-MRSA strain, was 
susceptible to the same antibiotics as ST239 and ST5 with the addition of 
ciprofloxacin, levofloxacin and gentamicin but highly resistant to erythromycin and 
clindamycin [75]. Xie et al. reported that HA-MRSA isolates had significantly higher 
rates of resistance compared to CA-MRSA isolates for ciprofloxacin, moxifloxacin, 
rifampicin, clindamycin, tetracycline [87]. All isolates were susceptible to 
vancomycin, teicoplanin and linezolid. 
Xiao et al. found that resistance varied even within different spa types of ST 
defined strains [86]. All ST239-III-t030 were resistant to ciprofloxacin and rifampin. 
However, susceptibility to trimethoprim-sulfamethoxazole demonstrated only 8.2% 
of ST239-III-t037 isolates with the same resistance patterns. ST5-II isolates were 
more likely to be resistant to ciprofloxacin. The majority of ST59-IV isolates were 
susceptible to ciprofloxacin, rifampin and trimethoprim-sulfamethoxazole. In the 
study by Li et al. the variability of resistance profiles was also seen between 
isolates containing the sasX virulence gene [40]. The rates of resistance for 
ST239-III with sasX genes for clindamycin, ciprofloxacin, erythromycin, 
trimethoprim-sulfamethoxazole were significantly higher compared to isolates 
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without the sasX gene. This demonstrates the high variability of antibiotic 
resistance profiles even within the same sequence types. None of the isolates 
were resistant to vancomycin. Differences in resistance was also seen between 
PFGE pulsotypes where Li et al. identified significant differences in 
chloramphenicol resistance and differences in chloramphenicol and ciprofloxacin 
resistance in the ST59 SCCmec types IV and V [39]. 
When examining different sites of colonization Zhang J et al. identified that 
patterns of resistance were similar for most antibiotics across nasal, axillary and 
skin sites [90]. However, there were differences with certain antibiotics with 
gentamicin having lower resistance in nasal isolates compared to other sites and 
lower tetracycline resistance in skin isolates.  
There is concern of major clones developing resistance to new drugs with 
the implication of limiting treatment options or selective pressure. Zhang H et al. 
investigated MRSA susceptibility to ceftaroline, a newer cephalosporin in isolates 
across China [89]. ST239-III, a major HA-MRSA in China, was responsible for the 
majority of ceftaroline resistant isolates. Despite these concerns, these strains 
were still susceptible to vancomycin, norvancomycin, linezolid and teicoplanin. All 
the studies in this review demonstrated that vancomycin resistance (MIC >2ug/ml) 
was not detected in any isolates. However, it is known that China does have 
evidence of high vancomycin resistance rates which were not captured in this 
literature review [70]. 
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Table 4. Overall antibiotic resistance rates for studies in China 
 The table lists all the antibiotics tested for resistance and provides the overall resistance 
rate (%) for each study in China. The percentages represent the resistance rate in all samples from 
each study which contain combinations of CA-MRSA and HA-MRSA isolates. Xiao et al. [86] was 
not included as the authors did not provide drug specific resistance rates. 
 
Antibiotics Cheng 
et al. 
(2013) 
Li et 
al. 
(2013) 
Tian et 
al. 
(2013) 
Li et 
al. 
(2014)  
Zhang 
J et al. 
(2015) 
Zhang 
H et al. 
(2015)  
Xie et 
al. 
(2016) 
Ampicillin 99.4       
Cefoxitin  100    100  
Cefuroxime  67  74.5    
Chloramphenicol  33  13.6 2.1   
Ciprofloxacin 80.2 11.7 91.7 63.8 34.7 78.5 69.4 
Clindamycin 80.9 93.6 91.7 83.5 18.4 83.7 93.5 
Erythromycin 86.2 99.1 99.4 81.1 41.1 87.6 93.3 
Fusidic acid  0   2.1   
Gentamicin 77.3 21.4 90 57.6 9.2  61.3 
Kanamycin     38.3   
Levofloxacin 81.7  86.7   76.9  
Linezolid 0.3 0   0 0 0 
Minocycline     9.2   
Moxifloxacin 31.9     53.4 31.1 
Mupirocin  0      
Nitrofurantoin 0.9  51.6     
Oxacillin 97.6   100 48.2   
Penicillin 100 97.1  100 89.4   
Quinupristin-
Dalfopristin 3    0   
Rifampicin 39.1 10.7  54.3 0 59.8 22.6 
Teicoplanin 0.9  0  0 0 0 
Tetracycline 68.8 44.6  74.1 24.8   
Tigecycline  0    0  
Tobramycin     37.6   
Trimethoprim-
Sulfamethoxazole 24.1 10.7 11.6 8 0.7  38.7 
Vancomycin 0 0 0 0 0 0 0 
Ceftaroline      0  
Norvancomycin      0  
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Taiwan and Hong Kong 
Within Taiwan and Hong Kong the resistant profiles among MRSA clones 
were unique in their molecular characteristics. The most common antibiotics tested 
for MRSA resistance were ciprofloxacin, clindamycin, erythromycin, gentamicin, 
trimethoprim-sulfamethoxazole, and vancomycin (Table 5). Differences in 
resistance rates between SCCmec types II and III to SCCmec types IV and V were 
seen in multiple studies. Lee et al. found that patients and healthcare workers with 
SCCmec types IV and V were resistance to fewer antibiotics compared to those 
infected with SCCmec types II and III [38]. The antibiotic profiles for the SCCmec 
types II and III in this study were almost all identical. Kuo et al. showed SCCmec 
types II and III to be more resistant to ciprofloxacin, levofloxacin, trimethoprim-
sulfamethoxazole, and vancomycin compared to other SCCmec types [35]. 
SCCmec type III had the highest rate of resistance to vancomycin compared to 
other SCCmec types II, IV and V. Isolates with SCCmec types IV and V were more 
susceptible to gentamicin but higher resistance to rifampicin compared to SCCmec 
II and III. The same study also reported high rates of resistance to linezolid, 
tigecycline, and daptomycin across all isolates [25]. Kang et al., when investigating 
ocular samples found that all SCCmec type IV and V were completely or highly 
susceptible to all antibiotics except for clindamycin, erythromycin, cefoxitin, and 
penicillin [30]. The HA-MRSA with SCCmec types I, II and III had significantly 
higher rates of resistance except for vancomycin, and teicoplanin where no 
resistance was seen to these two antibiotics. The distinction between HA- and CA-
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MRSA associated SCCmec types was also seen in isolates taken from nursing 
homes. Tsao et al. reported that MRSA isolates carrying the same SCCmec type 
had similar antimicrobial susceptibility patterns [76]. MRSA isolates with SCCmec 
III were multi-resistant to erythromycin, ciprofloxacin, trimethoprim–
sulfamethoxazole, and clindamycin. In this study all isolates were susceptible to 
linezolid, vancomycin, and teicoplanin. From all the studies in Taiwan, only Kuo et 
al. [35] and Lin et al. [41] reported intermediate vancomycin resistance in a low 
proportion of their isolates. 
 In Hong Kong, Ho PL et al. found that 60.7% of MRSA isolates were 
resistant to erythromycin, 60.6% to clindamycin, 17.9% to gentamicin, 32.1% to 
tetracycline, 14.3% to chloramphenicol, and 25% to ciprofloxacin [22]. ST59-IV/V 
isolates were resistant to chloramphenicol, erythromycin, and tetracycline. ST45-
IV/V isolates were resistant to ciprofloxacin erythromycin, gentamicin, and 
tetracycline. Trimethoprim-sulfamethoxazole, minocycline, fusidic acid, and 
rifampicin were active against all isolates in this study [22].  
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Table 5. Overall antibiotic resistance rates for studies in Taiwan and Hong 
Kong 
The table lists all the antibiotics tested for resistance and provides the overall resistance 
rate (%) for each study in Taiwan and Hong Kong*. The percentages represent the resistance rate 
in all samples from each study which contain combinations of CA-MRSA and HA-MRSA isolates. 
Different MIC cut-offs were reported† when resting vancomycin resistance, Kuo et al. [35] used 
>1ug/mL and Lin et al. [41] used 2ug/mL. 
 
Antibiotics Lee et 
al 
(2011) 
Ho et 
al 
(2012) 
Kuo 
et al 
(2012) 
Lin et 
al 
(2013) 
Kang 
et al 
(2015) 
Tsao 
et al 
(2015) 
Ho PL 
et al* 
(2012) 
Ampicillin    98.4    
Cefuroxime     0   
Chloramphenicol       14.3 
Ciprofloxacin 78.9  79.5 46.8 33.3 60 25 
Clindamycin 89.5 85.4 83.6  93.9 27 60.6 
Doxycycline      1  
Daptomycin   0 0    
Erythromycin 89.5 91.7  93.3 93.9 62 60.7 
Fusidic acid    1.6  22 0 
Gatifloxacin     27.3   
Gentamicin 89.5  81.1 48.4   17.9 
Levofloxacin  67.7 78.42  30.3   
Linezolid  0 0 0    
Minocycline 0       
Moxifloxacin    37.1 24.2  0 
Oxacillin 84.2       
Penicillin 100    100   
Rifampicin   1.8 9.7   0 
Teicoplanin  0  0 100   
Tetracycline  32.3  48.4   32.1 
Tigecycline   0.8     
Trimethoprim-
Sulfamethoxazole  39.6 54.1 30.6  8 0 
Vancomycin 0 0 18.8† 8.1† 0   
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South Korea and Japan 
 For South Korea and Japan, the most commonly tested antibiotics were 
clindamycin, erythromycin, gentamicin, trimethoprim-sulfamethoxazole, and 
vancomycin (Table 6). In South Korea unique antibiotic resistance profiles were 
identified based on different ST and SCCmec types. Kim et al. reported resistant 
profiles based on MLST [32]. The two major clones ST5-II and ST239-III had 
differing antibiotic patterns. Of ST5-II isolates, 99% were resistant to erythromycin, 
88% to clindamycin, 99% to ciprofloxacin, 93% to gentamicin, 13% to rifampicin, 
and 4% to trimethoprim-sulfamethoxazole. For ST239-III, all isolates were 
resistant to erythromycin, gentamicin but 89% were resistant to clindamycin, 98% 
to ciprofloxacin, 4% to rifampicin, and 88% to trimethoprim-sulfamethoxazole. The 
CA-MRSA clone ST72 was more susceptible to antibiotics compared to ST5 and 
ST239 in this study, specifically clindamycin, ciprofloxacin and gentamicin. 
Sung et al. reported from tertiary hospitals among CA-MRSA isolates, 
resistance rates to gentamicin, ciprofloxacin, tetracycline, and trimethoprim-
sulfamethoxazole were lower than those of HA-MRSA isolates [71].  Rifampicin 
and erythromycin resistance rates were similar between CA-MRSA and HA-
MRSA, and none of the SCCmec type II or III isolates were susceptible to 
erythromycin. There were more HA-MRSA clones that were resistant to multiple 
antibiotics compared to CA-MRSA clones. The vancomycin susceptibility 
breakpoint used an MIC of <2ug/ml in this study, and 6 isolates had an MIC of 
≥2ug/mL with 5 of them SCCmec type II and III.  
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Studies in Japan demonstrated a wide variety of resistance patterns in 
MRSA isolates from hospital settings across the country. Molecular differences by 
SCCmec type were seen in the study by Inomata et al. using a POT analysis to 
predict SCCmec types found similar resistance profiles in isolates by the same 
SCCmec type [26]. Higher rates of resistance were found in isolates with SCCmec 
types I, II and III compared to SCCmec types IV and V. The antibiotic resistance 
rates were similar across all CA-MRSA and HA-MRSA and predicted SCCmec 
types for penicillin, oxacillin, ampicillin, cefoxitin ceftriaxone, amikacin, rifampicin, 
trimethoprim-sulfamethoxazole, and arbekacin but differed for the remaining 
antibiotics tested. All of the 219 isolates were resistant to penicillin, ampicillin, and 
cefoxitin, but were not resistant to linezolid, teicoplanin, or vancomycin. More than 
90% of the isolates were resistant to oxacillin, ceftriaxone, and erythromycin while 
susceptible to rifampicin, trimethoprim-sulfamethoxazole, and arbekacin. 
Variability within SCCmec types by PFGE pulsotypes was identified in the study 
by Nakaminami et al. where multiple pulsotypes of ST764-II, a ST5 variant, had 
differences in resistance between PFGE pulsotypes [49]. The ST764-II strain 
found across multiple PFGE puslotypes was resistant to multiple antibiotics with 
the epidemic pulsotype I being resistant to fluoroquinolones, macrolides, 
gentamicin, and minocycline tested in the study.  
 The Otsuka et al. [54] and Mine et al. [48] studies were conducted on islands 
which were geographically separate from the mainland of Japan. Otsuka et al. 
reported 68.3% of MRSA isolates were resistant to gentamicin and erythromycin, 
	 40 
58.5% were resistant to clindamycin, 31.7% to minocycline and 34.1% to 
fosfomycin. No resistance was observed for arbekacin, trimethoprim-
sulfamethoxazole, teicoplanin or vancomycin in all isolates. Mine et al. only 
conducted antibiotic susceptibility testing on only isolates containing PVL genes, 
which were typically CA-MRSA [48]. A ST8-IV clone with PVL genes (USA300) 
was found to have resistance to erythromycin, gentamicin, and levofloxacin 
indicating the potential difficulty that physicians may find when treating and 
managing community onset skin and soft tissue infections due to MRSA isolates 
with PVL genes.  
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Table 6. Overall antibiotic resistance rates for studies in Japan and South 
Korea 
The table lists all the antibiotics tested for resistance and provides the overall resistance rate (%) 
for each study in South Korea* and Japan. The percentages represent the resistance rate in all 
samples from each study which contain combinations of CA-MRSA and HA-MRSA isolates. 
 
Antibiotics Kim et 
al* 
(2011) 
Sung et 
al* 
(2012) 
Otsuka 
et al 
(2012) 
Mine et 
al (2013) 
Nakaminami 
et al (2014) 
Inomata 
et al 
(2015) 
Amikacin      11.5 
Ampicillin   100  100 100 
Arbekacin   0  0 1.3 
Cefazolin      73.5 
Cefepime      72.1 
Cefoxitin      100 
Ceftriaxone      97.7 
Cefuroxime     98.2  
Ciprofloxacin 85.1 32.9     
Clarithromycin     97  
Clindamycin 79.9 32.9 58.5   67.1 
Doxycycline      46.6 
Erythromycin 96.5 62 68.3 58.8  96.8 
Fosfomycin   34.1    
Gentamicin 87.9 41.8 68.3 17.6 77.9 26.9 
Imipenem      57.1 
Levofloxacin    52.9 100 78.1 
Linezolid     0 0 
Minocycline   31.7  47 53.9 
Oxacillin   100  100 98.6 
Penicillin      100 
Rifampicin 20.9 2.5    0.5 
Sitafloxacin     63.2  
Spiramycin     95.6  
Sulbactam-
ampicillin      62.1 
Teicoplanin   0  0 0 
Tetracycline  44.3     
Trimethoprim-
sulfamethoxazole 25.9 15.2 0   2.3 
Vancomycin  7.6 0  0 0 
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PUBLIC HEALTH PERSPECTIVE 
The major countries of East Asia are only a subset of many other countries 
in a region known to have high levels of antimicrobial resistance [27]. In particular, 
the burden of MRSA in Asia has been increasing with concurrent increased genetic 
variation in this bacterium [7,25]. The major Far East countries examined by this 
literature demonstrate how this region of Asia contains a wide variety of MRSA 
clones. Across China and Taiwan there is a continued predominance of HA-MRSA 
clones in hospital settings. The primary concern about these HA-MRSA clones is 
the potential of these bacteria to obtain genetic components that confer resistance 
to additional antibiotics at a greater scale. The evidence of genetically novel strains 
across hospitals in Japan, South Korea, and primarily China, and single locus 
variants of major clones with greater resistance profiles also validate the issue of 
greater levels of antibiotic resistance in S. aureus, which has implications in 
protecting health across populations. 
Alongside the evolution of S. aureus obtaining antibiotic resistance 
phenotypes, the invasion of genetically unique strains from the community into 
hospitals is currently occurring in Asia. The presence of MRSA in Chinese and 
Taiwanese healthcare centers is characterized by ST239-III and ST5-II strains 
which have been historically predominant. However increased reports of CA-
MRSA clones in hospitals is noted by the emergence of ST59-IV/V clones in these 
settings. Typical HA-MRSA clones in Japan and South Korea such as ST5-II are 
becoming overshadowed by local and foreign CA-MRSA clones such as ST59-IV, 
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ST72-IV and ST8-IV. The specific concern for CA-MRSA in hospital settings is the 
acquisition of multi-drug resistance characteristics typically seen in HA-MRSA 
strains. The possibility of a widely pervasive international CA-MRSA clone 
obtaining high levels of antibiotic resistance fits the pandemic profile that can 
threaten public health at a global level. This literature review demonstrates the high 
level heterogeneity of antibiotic resistance across hospitals in the major Far East 
countries. With the continual development of technology to accurately characterize 
genetic and molecular features of MRSA, timely techniques with clinical relevance 
will be important for making informed treatment choices to not only ensure the 
recovery of the patient but also to provide accurate surveillance that can track the 
evolution of MRSA temporally and over geographic areas. These new 
developments in technologies can help improve tracing and infection control in 
outbreaks occurring outside of healthcare settings. The ability of molecular 
characterization techniques to identify and differentiate clones will be a 
fundamental tool in understanding risk factors associated with MRSA infection 
unique to the major Far East countries. Individual countries should develop and 
strengthen surveillance programs within hospitals and communities.  
As the region of Asia is comprised of a wide variety of different countries, 
cultures, peoples, and health systems it is difficult to construct a uniform strategy 
to combat MRSA and other pathogens with high antibiotic resistance potential. In 
order to control the continued emergence of MRSA in this continent, a focused 
effort towards collaborative surveillance across Asia must be a priority in order to 
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decrease the overall burden of MRSA in the region and slow the progression of 
antibiotic resistance. Data on MRSA in countries outside of China, Japan, Hong 
Kong, Taiwan, and South Korea is lacking and further collaborative research 
should be conducted for high risk populations to understand the full extent of the 
health burden caused by MRSA across Asia.  
Especially in the age of globalization and high volumes of international 
travel, it is not surprising there is evidence for the clonal dissemination of MRSA 
within and between countries of different continents. Abundant evidence 
demonstrating the role of globalization was found through in multiple studies 
through this literature review. For example, the isolates found in a Shenyang 
hospital from the northeastern region of China are similar to HA-MRSA strains in 
the adjacent country of South Korea [75]. Moreover, the study reporting the 
dominant United States CA-MRSA clone ST8-IV strain with PVL genes (USA300) 
in South Korean hospitals [37] and, in Japan, the potential source of ST8-IV strains 
on the island of Okinawa is a local United States military base [48]. In addition, half 
of the staff in the nursing homes studied by Tsao et al. in Taiwan were long-term 
foreign workers and the results suggested that these workers are a potential risk 
factor for MRSA carriage; brings the question whether foreign long term care 
workers should be screened for MRSA carriage in these environments [76]. 
Prevention and control are important considerations to decrease the 
incidence and burden disease caused by MRSA. Resources allocated to screening 
for MRSA should be directed by information based on the combination of known 
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epidemiological risk factors and molecular evidence. Environments of close 
contact, poor hygiene or sharing of equipment should have more rigorous 
prevention programs. For outbreaks, screening should be mandatory especially in 
hospital settings and an emphasis on extensive environmental and fomite 
surveillance should also be considered. 
An important consideration which was not covered in this literature review 
is the role of livestock in MRSA carriage and transmission to humans. MRSA has 
been known to infect a wide range of animal species including common agricultural 
livestock [82]. There are previous reports of human infection from livestock-
associated MRSA strains and there is a recent influx of literature on this topic [11, 
82]. As Asia supports a large proportion of the worlds total livestock, the potential 
for more zoonotic infections is possible. Livestock-associated MRSA may add 
another layer to the blurring between community- and hospital-associated MRSA 
infections.  
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CONCLUSION 
MRSA has established itself as a successful pathogen that has and 
continues to emerge in countries throughout the world. The decreasing reliability 
of an epidemiological definition of MRSA and evidence for the invasion of CA-
MRSA clones into hospital settings in East Asia emphasizes the importance of 
molecular characterization to accurately identify MRSA isolates for clinical and 
public health decisions. There is a wide genetic variety of MRSA clones in the Far 
East and high levels of antibiotic resistance. Existing surveillance systems should 
be strengthened to detect molecular changes of major MRSA clones and to identify 
novel strains circulating in the hospital and in communities. Countries lacking 
information on local MRSA infections should allocate resources to investigate 
predominant MRSA clones within their borders to contribute to the growing body 
of knowledge of MRSA in Asia.  Finally coordinated efforts between countries 
should be pursued to conduct appropriate surveillance to understand the etiologies 
and movement of successful MRSA clones in this region. 
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